Search

Your search keyword '"Mikael H. Sodergren"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Mikael H. Sodergren" Remove constraint Author: "Mikael H. Sodergren" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
47 results on '"Mikael H. Sodergren"'

Search Results

1. Cannabidiol’s cytotoxicity in pancreatic cancer is induced via an upregulation of ceramide synthase 1 and ER stress

2. A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance

Catalog

Books, media, physical & digital resources

3. UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder

4. An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry

6. Cannabis use in the UK: a quantitative comparison of individual differences in medical and recreational cannabis users

7. Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine

8. Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry

9. A Case Report on Longitudinal Collection of Tumour Biopsies for Gene Expression-Based Tumour Microenvironment Analysis from Pancreatic Cancer Patients Treated with Endoscopic Ultrasound Guided Radiofrequency Ablation

10. UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes

11. Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry

13. Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network

14. Medical cannabis and attention-deficit hyperactivity disorder

15. Medical cannabis and neurological disorders: a clinical overview

17. Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy—Analysis from the UK Medical Cannabis Registry

18. Quality of life after pancreatic surgery – A systematic review

19. UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder

20. Supplementary Figure 4 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

21. Supplementary Legends from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

22. Supplementary Figure 5 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

23. Supplementary Figure 1 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

24. Appendix A from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

25. Supplementary Tables from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

26. Data from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

27. Supplementary Figure 3 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

28. Supplementary Figure 2 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

29. An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry

30. Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK Medical Cannabis Registry

32. Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study

34. UK Medical Cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions

35. Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry

36. The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry

37. Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry

38. Patient priorities for research: A focus group study of UK medical cannabis patients

39. Medical cannabis, CBD wellness products and public awareness of evolving regulations in the United Kingdom

40. UK medical cannabis registry: a patient evaluation

41. Cannabis-based medicinal products: a clinical guide

42. Perceived Stigma of Patients Undergoing Treatment with Cannabis-Based Medicinal Products

43. An updated analysis of clinical outcome measures across patients from the UK medical cannabis registry

44. UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes

45. The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis

46. UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia

47. UK Medical Cannabis Registry: A Patient Evaluation.